The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils
Abstract
Background/objectives Reduced consumption of trans-fatty acids (TFA) is desirable to lower coronary heart disease (CHD) risk. In practice, partially hydrogenated vegetable oils (PHVO) that contain both TFAs and other fatty acids are the unit of replacement and could be replaced with diverse alternative fats and oils. We performed quantitative estimates of CHD effects if a person's PHVO consumption were to be replaced with alternative fats and oils based on (1) randomized dietary trials and (2) prospective observational studies.Subjects/methods We performed meta-analyses of (1) the effects of TFAs on blood lipids and lipoproteins in controlled dietary trials and (2) associations of habitual TFA consumption with CHD outcomes in prospective cohort studies. On the basis of these results and corresponding findings for saturated fatty acids (SFA), cis-monounsaturated fatty acids (MUFA) and cis-polyunsaturated fatty acids (PUFA), we calculated the effects on CHD risk for replacing 7.5% of energy from three different PHVO formulations (containing 20, 35 or 45% TFAs) with butter, lard, palm or vegetable oils.Results In controlled trials, each 1% energy replacement of TFAs with SFAs, MUFAs or PUFAs, respectively, decreased the total cholesterol (TC)/high-density lipoprotein cholesterol (HDL-C) ratio by 0.31, 0.54 and 0.67; the apolipoprotein (Apo)-B/ApoAI ratio by 0.007, 0.010 and 0.011; and lipoprotein (Lp)(a) by 3.76, 1.39 and 1.11 mg/l (P<0.05 for each). We also included possible effects on C-reactive protein (CRP) of TFAs vs other fats from one trial. On the basis of these risk factor changes in controlled trials, CHD risk would be variably decreased by different fats and oils replacing 7.5% of energy from 20% TFA PHVO (CHD risk reduction: -2.7% (butter) to -9.9% (canola)); 35% TFA PHVO (-11.9% (butter) to -16.0% (canola)); or 45% TFA PHVO (-17.6% (butter) to -19.8% (canola)). In prospective cohort studies, each 2% energy replacement of TFAs with SFAs, MUFAs or PUFAs would lower CHD risk by 17% (95% confidence interval (CI)=7-25%), 21% (95% CI=12-30%) or 24% (95% CI=15-33%), respectively. On the basis of these associations in observational studies, CHD risk would be variably decreased by different fats and oils replacing 7.5% of energy from 20% TFA PHVO (CHD risk reduction: +0.5% (butter) to -21.8% (soybean)); 35% TFA PHVO (-14.4% (butter) to -33.4% (soybean)); or 45% TFA PHVO (-22.4% (butter) to -39.6% (soybean)). The demonstrated effects on TC/HDL-C, ApoB/ApoAI, Lp(a), and CRP in randomized feeding trials together accounted for approximately 65-80% and approximately 50% of the estimated risk reduction for replacing PHVO with animal fats and vegetable oils, respectively, that would be calculated from prospective cohort studies.Conclusions Effects on CHD risk of removing PHVO from a person's diet vary depending on the TFA content of the PHVO and the fatty acid composition of the replacement fat or oil, with direct implications for reformulation of individual food products. Accounting for the summed effects of TFAs on multiple CHD risk factors provides more accurate estimates of potential risk reduction than considering each risk factor in isolation, and approaches the estimated risk reduction derived from prospective cohort studies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Replacing 1% energy of trans fatty acids with saturated, monounsaturated, or polyunsaturated fatty acids decreases the total cholesterol/HDL cholesterol ratio by 0.31, 0.54, and 0.67, respectively.283”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [283]
In the citing paper
“Substituting calories from mono- or poly-unsaturated fat with trans fatty acids increases LDL cholesterol, apolipoprotein B, triglycerides, and lipoprotein(a), and lowers plasma high-density lipoprotein cholesterol and apolipoprotein A1 levels (44).”
From Health Benefits of the Mediterranean Diet: Metabolic and Molecular Mechanisms (2018) · cites this paper as [44]
In the citing paper
“Weight loss has a beneficial effect on lipids and lipoproteins.”
From Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association (2011) · cites this paper as [385]
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 1×
“Summary estimates were obtained using random effects meta-analysis weighted by the inverse variance log RRs of the individual studies (DerSimonian and Laird, 1986).”
MethodYusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Danesh, J., Wheeler, J. G., Hirschfield, G. M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G. D. O., Pepys, M. B., & Gudnason, V. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032804 · Cited by 2,953 · cited 2×
“For an estimated 1.2 mg/l higher CRP, the RR was 1.58 (95% CI¼1.48–1.68) (Danesh et al., 2004).”
MethodInfluentialMensink, R. P., Zock, P. L., Kester, A. D., & Katan, M. B. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.5.1146 · Cited by 2,811 · cited 1×
“The effects on blood lipid concentrations of isocaloric changes between consumption of SFAs, MUFAs and PUFAs were calculated from a prior meta-analysis of randomized controlled dietary trials (Mensink et al., 2003).”
Method(2007) · The Lancet · doi:10.1016/s0140-6736(07)61778-4 · Cited by 2,331 · cited 3×
“For a 1.33 decrease in the TC/HDL-C ratio, the relative risk (RR) of CHD (weighted across age groups) was 0.61 (95% confidence interval (CI)¼0.55–0.69) after correction for regression dilution bias (Prospective Studies Collaboration, 2007).”
BackgroundMethodInfluentialDietary Fat Intake and the Risk of Coronary Heart Disease in Women
Hu, F. B., Stampfer, M. J., Manson, J. E., Rimm, E., Colditz, G. A., Rosner, B. A., Hennekens, C. H., & Willett, W. C. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711203372102 · Cited by 1,782
Trans fatty acids and cardiovascular disease
Mozaffarian, D., Katan, M. B., Ascherio, A., Stampfer, M. J., & Willett, W. C. (2006) · New England Journal of Medicine · doi:10.1056/nejmra054035 · Cited by 1,752 · cited 11×
“…controlled feeding trials and of associations of habitual TFA consumption with clinical endpoints in prospective cohort studies, the estimated effects on CHD risk of replacing TFAs with equivalent calories from carbohydrate or cis-unsaturated fats has been estimated (Mozaffarian et al., 2006).”
BackgroundResultInfluentialSelf-citationMensink, R. P., & Katan, M. B. (1990) · New England Journal of Medicine · doi:10.1056/nejm199008163230703 · Cited by 1,424 · cited 2×
“included 66 dietary interventions (‘diets’) among men and women involving a total of 518 individuals (Laine et al., 1982; Mensink and Katan, 1990; Zock and Katan, 1992; Judd et al., 1994, 1998, 2002; Almendingen et al., 1995; Aro et al., 1997; Muller et al., 1998; Lichtenstein et al., 1999; de Roos et al., 2001; Lovej…”
BackgroundIntake of trans fatty acids and risk of coronary heart disease among women
WILLETT, W. (1993) · The Lancet · doi:10.1016/0140-6736(93)90350-p · Cited by 1,025 · cited 2×
“For example, the use of objective biomarkers of TFA consumption (for example, erythrocyte membrane levels) (Sun et al., 2007) reveals stronger associations between TFA intake and CHD risk than the use of dietary questionnaires (Willett et al., 1993; Hu et al., 1997; Oh et al., 2005).”
BackgroundLipoprotein(a) and Coronary Heart Disease: Meta-Analysis of Prospective Studies
Danesh, J., Collins, R., & Peto, R. (2000) · Circulation · doi:10.1161/01.cir.102.10.1082 · Cited by 938 · cited 2×
“…TC/HDL-C, ApoB/ApoAI, Lp(a) and CRP if 7.5% of energy from PHVO were replaced with alternative fats and oils were calculated using established relationships between these risk factors and the incidence of CHD (Danesh et al., 2000, 2004; Yusuf et al., 2004; Prospective Studies Collaboration, 2007).”
BackgroundMethodInfluential
Cited by
Items 201–300 of 409
Sarwar, S., Shaheen, N., Ashraf, M. M., Bahar, N., Akter, F., Hossain, M. M., Mridha, M. K., Kajal, M. A. M., Rasul, S. S. B., Khondker, R., et al. (2024) · Food Chemistry Advances · doi:10.1016/j.focha.2024.100611 · Cited by 14
The need for multisectoral food chain approaches to reduce trans fat consumption in India
Downs, S., Singh, A., Gupta, V., Lock, K., & Ghosh‐Jerath, S. (2015) · BMC Public Health · doi:10.1186/s12889-015-1988-7 · Cited by 18
“However, the health consequences of its consumption are clear – a 2 % increase in energy intake from trans fat has been associated with a 23 % increase in the risk of heart disease [1].”
BackgroundHissanaga, V. M., Proença, R. P. D. C., & Block, J. M. (2012) · Revista de Nutrição · doi:10.1590/s1415-52732012000400009 · Cited by 38
UK health performance: findings of the Global Burden of Disease Study 2010
Murray, C. (2013) · BDJ · doi:10.1038/sj.bdj.2013.400 · Cited by 14
Health and Nutritional Properties of Palm Oil and Its Components
Daud, Z. A. M., Kaur, D., & Khosla, P. (2012) · Elsevier eBooks · doi:10.1016/b978-0-9818936-9-3.50021-6 · Cited by 15
Misan, V., Estato, V., de Velasco, P. C., Fernandes, F. S., Magri, T., dos Santos, R. M. D. A. R., Fragoso, T., de Souza, A. S., Boldarine, V. T., Bonomo, I. T., et al. (2015) · Brain Research · doi:10.1016/j.brainres.2015.05.001 · Cited by 16
“However, due to adverse effects on health (Mozaffarian and Clarke, 2009; Sun et al., 2007), legislation in several countries, including Brazil, have been restricting the use of TF in foodstuff production (Ratnayake et al., 2014).”
BackgroundNutrient patterns are associated with discordant apoB and LDL: a population-based analysis
Mazidi, M., Webb, R. J., George, E. S., Shekoohi, N., Lovegrove, J. A., & Davies, I. G. (2021) · British Journal Of Nutrition · doi:10.1017/s000711452100369x · Cited by 15
“mainly consisting of the small, dense LDL subclass(41,42).”
Effect of rice bran oil spread on the physical, sensory and fatty acid profile of cake
Shaik, R., Kuna, A., Azam, M., Tilathoo, R., Kanuri, M., & Samala, G. (2017) · Journal of Food Science and Technology · doi:10.1007/s13197-017-2652-2 · Cited by 14
“Hydrogenated fat which is commonly used for production of various baked products could be harmful due to presence of higher amount of saturated fats as well as trans fats (Mozaffarian and Clarke 2009).”
BackgroundIs Trans Fatty Acid Still an Issue for Policy Makers in Iran? A Technical Report
Saghafi, Z., Zargaraan, A., Tabibiazar, M., & Hosseini, H. (2018) · Nutrition and Food Sciences Research · doi:10.29252/nfsr.5.2.47 · Cited by 13
“Among other adverse effects of TFAs, systemic inflammation, sudden cardiac death, gallstones, infertility and endothelial dysfunction can be mentioned (6-9).”
BackgroundDietary fat, salt, and sugar: a clinical perspective of the social catastrophe
Mukhopadhyay, S., Goswami, S., Mondal, S. A., & Dutta, D. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816918-6.00003-2 · Cited by 22
Bioprocess technologies for production of structured lipids as nutraceuticals
Ferreira‐Dias, S., Osório, N. M., & Tecelão, C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823506-5.00007-2 · Cited by 13
Kim, J. H., & Lim, J. S. (2022) · Life · doi:10.3390/life12091404 · Cited by 13
“67 by replacing each 1% energy of total fat with saturated fat, monounsaturated fatty acids (MUFA) and polyunsaturated fatty acids (PUFA), respectively in controlled trials [34,35].”
BackgroundNonpharmacological approaches for reducing serum low-density lipoprotein cholesterol
Griffin, B. A. (2014) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000078 · Cited by 13
“Data from prospective cohort and randomly controlled trials, and meta-analyses from these sources, provide incontrovertible evidence that the replacement of dietary SFAs with a carbon chain length of 12–16 carbons, by either polyunsaturated fatty acid (PUFA), monounsaturated fatty acid (MUFA) or carbohydrate, reduces…”
BackgroundTrans fatty acids—Occurrence, technical aspects, and worldwide regulations
Kıralan, M., Ketenoğlu, O., & Kıralan, S. S. (2021) · Studies in natural products chemistry · doi:10.1016/b978-0-12-819489-8.00018-1 · Cited by 14
Bendsen, N. T., Haugaard, S. B., Larsen, T. M., Chabanova, E., Stender, S., & Astrup, A. V. (2011) · Metabolism · doi:10.1016/j.metabol.2011.01.009 · Cited by 16
Aligning food-processing policies to promote healthier fat consumption in India
Downs, S., Thow, A. M., Ghosh‐Jerath, S., & Leeder, S. (2014) · Health Promotion International · doi:10.1093/heapro/dat094 · Cited by 14
“Decreasing trans-fat intakes by 1% has been associated with a 12% reduction in cardiovascular disease risk, demonstrating that even small changes in intakes have the potential to have a substantial impact on population health (Mozaffarian and Clarke, 2009).”
BackgroundChisaguano, A. M., Lozano, B., Moltó-Puigmartí, C., Castellote, A. I., Rafecas, M., & López‐Sabater, M. C. (2012) · Analytical Methods · doi:10.1039/c2ay26236c · Cited by 15
Cawley, J., Meyerhoefer, C. D., Gillingham, L. G., Kris‐Etherton, P. M., & Jones, P. J. H. (2016) · Journal of Medical Economics · doi:10.1080/13696998.2016.1240084 · Cited by 12
The Role of Diet in the Prevention and Treatment of Cardiovascular Disease
Richter, C. K., Skulas‐Ray, A. C., & Kris‐Etherton, P. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802928-2.00027-8 · Cited by 15
Monge‐Rojas, R., Colón‐Ramos, U., Jacoby, E., Alfaro, T., do Carmo, M. D. G. T., Villalpando, S., & Bernal, C. (2017) · Public Health Nutrition · doi:10.1017/s1368980017001227 · Cited by 12
“That is, there is a net health benefit even when replacing IP-TFA with tropical oils (rich in SFA)((29)), although benefits are projected to be greatest when vegetable oils with high unsaturated fatty acid content replace the IP-TFA.”
BackgroundInfluentialde Roos, B., Wanders, A. J., Wood, S. G., Horgan, G. W., Rucklige, G., Reid, M., Siebelink, E., & Brouwer, I. A. (2011) · PROTEOMICS · doi:10.1002/pmic.201100163 · Cited by 13
“Consumption of trans fatty acids has a more significant effect on risk of cardiovascular disease than intake of saturated fatty acids [17].”
BackgroundAronis, K. N., Joseph, R. J., Blackburn, G. L., & Mantzoros, C. S. (2011) · Metabolism · doi:10.1016/j.metabol.2011.04.003 · Cited by 13
Dietary Fatty Acids and the Metabolic Syndrome: A Personalized Nutrition Approach
O'Connor, S. E., & Rudkowska, I. (2018) · Advances in food and nutrition research · doi:10.1016/bs.afnr.2018.07.004 · Cited by 17
Downs, S., Thow, A. M., Ghosh‐Jerath, S., & Leeder, S. (2014) · Health Policy and Planning · doi:10.1093/heapol/czu031 · Cited by 11
“Although the WHO recommends replacement of both trans and saturated fat with unsaturated fats and metaanalyses have shown that replacement of both of these fats with unsaturated fats generated health benefits (Mozaffarian et al. 2010; Mozaffarian and Clarke 2009), this study suggests that palm oil may be regarded as h…”
BackgroundSpringmann, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-811660-9.00013-8 · Cited by 18
Rice, B. H., Kraft, J., Destaillats, F., Bauman, D. E., & Lock, A. L. (2012) · Journal of Nutrition · doi:10.3945/jn.112.160077 · Cited by 11
İşlek, D., Sözmen, K., Ünal, B., Guzman-Castillo, M., Vaartjes, I. C. H., Critchley, J., Capewell, S., & O’Flaherty, M. (2016) · BMC Public Health · doi:10.1186/s12889-015-2655-8 · Cited by 14
“5) RRR by replacing 1 % of energy from trans-fat with unsaturated fats for coronary heart disease [59] We assumed half effect for stroke”
BackgroundRisk Assessment of Exposure to Trans Fat in Canada
Krenosky, S., LAbb, M., Lee, N., Underhill, L., Vigneault, M., Godefroy, S. B., & Ratnayake, N. (2012) · International Food Risk Analysis Journal · doi:10.5772/56127 · Cited by 10
“A meta analysis of just the four prospective cohort studies estimated a 17%, 21% and 24% lower risk of CHD for every 2% of energy from trans fat intake that is replaced with SFA, cis MUFA and cis PUFA, respectively [7].”
BackgroundMethodKong, W., Wang, L., Xu, H., & Liu, D. (2023) · Journal of Food Processing and Preservation · doi:10.1155/2023/2567854 · Cited by 10
Ramprasath, V. R., Thandapilly, S. J., Yang, S., Abraham, A., Jones, P. J. H., & Ames, N. P. (2015) · Trials · doi:10.1186/s13063-015-1014-5 · Cited by 14
“MUFAs, one of the components of canola oil, help reduce CVD risk by lowering blood pressure, blood total cholesterol (TC), and low-density lipoprotein cholesterol (LDL-C) levels; inhibiting LDL-C oxidation [13–16]; and improving glycemic control [17–19].”
BackgroundEffect of N on Yield and Chemical Profile of Winter Canola in Mississippi
Zheljazkov, V. D., Vick, B. A., Ebelhar, W., Buehring, N. W., & Astatkie, T. (2013) · Journal of Oleo Science · doi:10.5650/jos.62.453 · Cited by 10
Dietary strategies for cardiovascular health
Dieter, B. P., & Tuttle, K. R. (2017) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2016.12.007 · Cited by 10
Богачевская, С. А., & Николаевич, Б. А. (2017) · Social Aspects of Population Health · doi:10.21045/2071-5021-2017-53-1-1 · Cited by 10
Dietary intervention to lower serum cholesterol.
Clifton, P. M., Colquhoun, D., Hewat, C., Jones, P. J. H., Litt, J., Noakes, M., O’Brien, R. C., Shrapnel, B., & Skeaff, M. (2009) · PubMed · Cited by 15
Nutritional characteristics of palm oil
Khosla, P. (2011) · Elsevier eBooks · doi:10.1533/9780857092472.1.112 · Cited by 12
Elimination of industrial Trans Fatty Acids from the food supply chain: With a focus on India
Paliwal, B. K., & Wan, M. (2024) · Food Chemistry Advances · doi:10.1016/j.focha.2024.100802 · Cited by 10
de Souza, A. M., Bezerra, I. W. L., Torres, K. G., Pereira, G. S., Costa, R. M., & Oliveira, A. G. (2025) · Nutrients · doi:10.3390/nu17152483 · Cited by 10
“Diets high in trans and saturated fats elevate low-density lipoprotein (LDL) cholesterol, accelerating atherosclerosis and cardiovascular disease [3].”
Novel high-oleic oil consumption for cardiometabolic health: a narrative review
Desjardins, L.-C., & Rudkowska, I. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2283719 · Cited by 10
“Then, their availability and consumption figures are overviewed while their effects on CVD risk factors are examined using recent randomized controlled trials (RCTs).”
InfluentialDowns, S., Thow, A. M., Ghosh‐Jerath, S., & Leeder, S. (2014) · Journal of Hunger & Environmental Nutrition · doi:10.1080/19320248.2014.908452 · Cited by 9
The role of fat in the diet - quantity, quality and sustainability
Sanders, T. A. B. (2010) · Nutrition Bulletin · doi:10.1111/j.1467-3010.2010.01824.x · Cited by 9
Gomes, A., Correia, G., Coelho, M., Araújo, J. R., Pinho, M. J., Teixeira, A. L., Medeiros, R., & Ribeiro, L. V. P. T. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.12.009 · Cited by 10
“In addition, consumption of trans FAs raises the levels of low-density lipoproteins and triglycerides; lowers the levels of high-density lipoproteins; induces an inflammatory response; and, even at low levels of intake, significantly increases the risk of coronary events [8,15].”
BackgroundMedeiros, L. D. B., Alves, S. P., Bessa, R. J. B., Soares, J. K. B., Costa, C. N. M., Aquino, J. D. S., Guerra, G. C. B., Araújo, D. F. D. S., Toscano, L. T., Silva, A. S., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-98248-6 · Cited by 10
Applications of Trait Enhanced Soybean Oils
Wilkes, R. S., & Bringe, N. A. (2015) · Wiley eBooks · doi:10.1002/9781118961117.ch5 · Cited by 9
Mohammadi‐Nasrabadi, F., Rashidimehr, A., Khoshtinat, K., Alhouei, B., Massomian, A., Rashidian, M., & Esfarjani, F. (2024) · Food Science & Nutrition · doi:10.1002/fsn3.4557 · Cited by 9
Krogager, T. P., Nielsen, L. V., Bak, S. Y., Young, C., Ferreri, C., Jensen, O. N., Højrup, P., Thoma, V., Thøgersen, I. B., & Enghild, J. J. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.03.023 · Cited by 8
Aali, Y., Shiraseb, F., Abaj, F., Koohdani, F., & Mirzaei, K. (2021) · BMC Medical Genomics · doi:10.1186/s12920-021-01114-7 · Cited by 9
Merino, J., Mateo‐Gállego, R., Plana, N., Bea, A. M., Ascaso, J. F., Lahoz, C., & Aranda, J. L. (2013) · PubMed · doi:10.3305/nh.2013.28.3.6363 · Cited by 12
“It is known that certain macronutrients and food groups, such as carbohydrates, fat or alcohol, increase TG concentration, however, the potential impact of the dietary patterns and the association between different dietary components in subjects with HTG is unknown.(11-13) The Spanish Atherosclerosis Society created i…”
Backgroundde la Torre‐Carbot, K., Chávez‐Servín, J. L., Reyes, P., Ferriz, R. A., Gutiérrez, E., Escobar, K., Aguilera, A., Anaya‐Loyola, M. A., García-Gasca, T., García, O. P., et al. (2015) · Universal Journal of Food and Nutrition Science · doi:10.13189/ujfns.2015.030102 · Cited by 8
“Admittedly, partially-hydrogenated oil increases LDL cholesterol and decreases HDL cholesterol [16,17,40], and probably, the cause for this was that the oil used partially contains unhydrogenated oil.”
BackgroundResultStrategies to achieve a healthy diet and health: reduction of trans fat and saturated fatty acids
Spajić, D. G. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817226-1.00004-7 · Cited by 8
Trans and conjugated fatty acids in dairy products: Cause for concern?
Jahreis, G., & Dawczynski, C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815603-2.00004-8 · Cited by 10
[Dietary trans-fatty acids and metabolic syndrome].
Kochan, Z., Karbowska, J., & Babicz-Zielińska, E. (2010) · PubMed · Cited by 20
FACTORES DE RIESGOS ALIMENTARIOS Y NUTRICIONALES EN ADULTOS CON DIABETES MELLITUS
Barrera, M. D. P., Pinilla, A. E., Caicedo, L. M., Castillo, Y., Lozano, Y. M., & Rodríguez, K. M. (2012) · Revista de la Facultad de Medicina · Cited by 8
Availability of Vegetable Edible Oils and Potential Health Implications in Kenya
Tuei, V. C. (2023) · OALib · doi:10.4236/oalib.1109756 · Cited by 8
Sources ofTransand Saturated Fatty Acids: In the Diets of Vancouver Children
Mulder, K., Ferdinands, A. R., Richardson, K. J., & Innis, S. M. (2013) · Canadian Journal of Dietetic Practice and Research · doi:10.3148/74.1.2013.7 · Cited by 7
Gates, L., Langley‐Evans, S. C., Kraft, J., Lock, A. L., & Salter, A. M. (2017) · British Journal Of Nutrition · doi:10.1017/s0007114517000137 · Cited by 8
“Poor maternal nutrition is frequently associated with low birth weight and subsequently increased susceptibility to hypertension, obesity, type 2 diabetes and atherosclerotic CVD(1–4).”
BackgroundInfluentialControversies and discrepancies in the effect of dietary fat and cholesterol on cardiovascular risk
Leong, W., Ngiam, J. N., Tan, R., Lim, S. L., & Poh, K. K. (2020) · Singapore Medical Journal · doi:10.11622/smedj.2020065 · Cited by 8
“resulting in higher LDL cholesterol, total cholesterol-HDL cholesterol ratio and lower HDL cholesterol, all of which are CVD risk factors.(35,36) Trials have suggested that higher TF dietary intake could either raise cholesteryl ester transfer protein (CETP) activity or reduce CETP inhibitor activity, thereby increasi…”
BackgroundDevelopment of a Method for Controlling Trans Fatty Acids in Meals—MCTM
Hissanaga, V. M., Block, J. M., & Proença, R. P. D. C. (2012) · Journal of Culinary Science & Technology · doi:10.1080/15428052.2012.650601 · Cited by 7
“Increased consumption of TFA has been associated with certain diseases, such as cardiovascular diseases (Costa, Bressan, & Sabarense, 2006; Martin et al., 2004; Mozaffarian, Aro, & Willet, 2009; Mozaffarian & Clarke, 2009; Sun et al. 2007), obesity (McCord, 2005), and cancer (Chajès et al., 2008).”
BackgroundMarklund, M., Aminde, L. N., Wanjau, M. N., Huang, L., Awuor, C., Steele, L., Cobb, L. K., Veerman, L. J., & Wu, J. H. Y. (2023) · BMJ Global Health · doi:10.1136/bmjgh-2023-012692 · Cited by 6
Nutrition and Cardiovascular Disease
Mozaffarian, D. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0398-6.00048-2 · Cited by 6
Self-citationYanovski, Z., Sacks, F. M., Smith, S. C., Svetkey, L. P., Wadden, T. A., Lee, I.-M. M., Lichtenstein, A. H., Loria, C. M., Millen, B. E., Eckel, H., et al. (2014) · Cited by 6
Creating the Future of Evidence-Based Nutrition Recommendations: Case Studies from Lipid Research
Dwyer, J. T., Rubin, K. H., Fritsche, K. L., Psota, T., Liska, D. J., Harris, W. S., Montain, S. J., & Lyle, B. J. (2016) · Advances in Nutrition · doi:10.3945/an.115.010926 · Cited by 7
Xia, J., Xiaorong, X. I. A., Wenyuan, W. A. N. G., Xia, J., & Li, M. (2020) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.66.577 · Cited by 6
Effects of Low Carbohydrate High Fat Nigerian-Like Diet on Biochemical Indices in Rabbits
Oboh, H. A., & Olumese, F. E. (2010) · Pakistan Journal of Nutrition · doi:10.3923/pjn.2010.245.249 · Cited by 6
Industrially produced trans fat and saturated fat content of food products in Jamaica
Perry, R., Henry, F. J., & Bremmer, D. (2023) · Revista Panamericana de Salud Pública · doi:10.26633/rpsp.2023.45 · Cited by 8
“The existence of saturated fat and IP-TFA in the food system compounds the public health problem faced by many countries, as both are major dietary risk factors for NCDs. Front-of-package warning labeling and marketing restrictions are interventions that have been used to help in spurring reformulation efforts.”
BackgroundInfluentialTriglycerides and Cardiovascular Disease : A Scientific Statement From the
Pennathur, S., Kris‐Etherton, P. M., Lennie, T. A., Levi, M., Mazzone, T., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Stone, N. J., Ballantyne, C. M., et al. (2011) · Cited by 6
Rosales, M. F. E., Ariza‐Ortega, J. A., Ramos-Cassellis, M. E., Castañeda-Antonio, D., Romo-Gómez, C., Díaz-Reyes, J., Ramírez‐Moreno, E., Alanís‐García, E., Cruz‐Cansino, N. D. S., Cabrera, G. B., et al. (2019) · European Food Research and Technology · doi:10.1007/s00217-019-03272-6 · Cited by 8
Shibamoto, S., Gooley, A. A., & Yamamoto, K. (2014) · Lipids · doi:10.1007/s11745-014-3966-8 · Cited by 6
Trans Fatty Acids and Mortality
Delgado, G. E., & Kleber, M. E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811297-7.00026-3 · Cited by 10
Adamczyk, D., & Maison, D. A. (2021) · Foods · doi:10.3390/foods10102380 · Cited by 5
Park, J.-Y. K., & Koehler, K. M. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz170 · Cited by 5
The effects of low-calorie diet with canola oil on blood lipids in hyperlipidemic patients
Noroozi, M., Zavoshy, R., & Hashemi, H. (2009) · Cited by 6
Akoh, C. C., & Pande, G. (2020) · Wiley eBooks · doi:10.1002/047167849x.bio085 · Cited by 5
Legislation, Industrial Feasibility, and Scalability of Oleogel Production Processes
Scharfe, M. (2024) · Springer eBooks · doi:10.1007/978-3-031-46831-5_27 · Cited by 5
Marklund, M., Billyrose, S., Orji, I. A., Ikechukwu-Orji, M. U., Okoro, C. E., Obagha, C., Iyer, G. Y. N., Jamro-Comer, E., Ojo, A. E., Harris, W. S., et al. (2024) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2024.10.019 · Cited by 4
Walker, C. G., & Jebb, S. A. (2012) · Current Nutrition Reports · doi:10.1007/s13668-012-0017-z · Cited by 4
“Reductions in total fat, saturated fatty acids, and trans-fatty acids are all effective in reducing total cholesterol, LDL cholesterol, and triglycerides [4–6].”
BackgroundLICHTENSTEIN, H., Loria, C. M., Millen, B. E., Miller, N. H., Nonas, C., Eckel, R. H., Jakicic, J. M., Ard, J. D., Hubbard, S. M., Jesus, J. M. D., et al. (2013) · Cited by 4
Atreya, A. R., Kamath, A., Varma, M. D., & Nair, S. (2010) · International journal of collaborative research on internal medicine & public health · Cited by 4
Jamshidi‐Naeini, Y., Moyo, G., Napier, C. E., & Oldewage-Theron, W. H. (2021) · South African Journal of Clinical Nutrition · doi:10.1080/16070658.2021.1947039 · Cited by 5
“Substitution of total fat or SFA with carbohydrates is not associated with reduced risk of CHD. Conversely, there is convincing evidence that substituting PUFA for SFA is associated with reduced risk of CHD events and deaths.74,91,92 It has been shown that for every 1% energy supplied by PUFA instead of SFA, incidence…”
BackgroundInfluentialDas, A., Sanakal, S. I., Sahu, D., Sahoo, S., Adhya, P., Ravi, S., Chakraborty, S., Mohanty, B., Pal, K., & Maji, S. (2023) · Crystal Growth & Design · doi:10.1021/acs.cgd.3c01062 · Cited by 4
Nutritional optimization—reduced-sugar products and challenges
O’Sullivan, M. G. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819741-7.00002-x · Cited by 6
Sofi, F., Rapini, D., Innocenti, G., Abbate, R., Gensini, G. F., & Casini, A. (2009) · Cardiology in the Young · doi:10.1017/s104795110999120x · Cited by 4
Klötzel, M., Ehlers, A., Niemann, B., Buhrke, T., & Lampen, A. (2013) · Nutrition and Cancer · doi:10.1080/01635581.2013.742554 · Cited by 4
“It was reported that TFA intake might induce or support systemic inflammation and endothelial dysfunction (7,8), increases blood lipids and lipoproteins (9), and may induce insulin resistance thereby supporting the development of diabetes and adiposity (10–12).”
BackgroundMilajerdi, A., Maghsoudi, Z., & Ghiasvand, R. (2016) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2016.01.010 · Cited by 5
Taking Trans Fats Out of the Food Supply
Madhujith, T., & Sivakanthan, S. (2020) · Springer eBooks · doi:10.1007/978-981-15-3673-1_13 · Cited by 4
Characterisation of Bresaola Products Made from Beef, Veal, Wagyu, Mutton and Lamb
Zhang, R. (2015) · Tuwhera (Auckland University of Technology) · Cited by 4
Effect of Dietary Fatty Acid Intake on Cardiovascular Disease
Joris, P. J., & Mensink, R. P. (2015) · Elsevier eBooks · doi:10.1016/b978-1-78242-247-1.00007-7 · Cited by 5
Babayemi, A. K., Onukwuli, O. D., Eluno, E. E., & Otolorin, J. A. (2021) · Environmental Quality Management · doi:10.1002/tqem.21729 · Cited by 3
Shim, J. E., Lee, Y., & Song, S. (2023) · Epidemiology and Health · doi:10.4178/epih.e2023069 · Cited by 3
“The type of dietary fatty acid consumed primarily influences blood lipid and lipoprotein profiles [3-5].”
BackgroundOil Palm: Genome Designing for Improved Nutritional Quality
Ithnin, M. B., Othman, A., Tahir, N. I., Babu, B. K., Halim, M. A. A., & Rajesh, M. K. (2023) · Springer eBooks · doi:10.1007/978-981-19-4169-6_22 · Cited by 3
Marklund, M., Aminde, L. N., Wanjau, M. N., Ale, B. M., Ojo, A. E., Okoro, C. E., Adegboye, A. O., Huang, L., Veerman, L. J., Wu, J. H. Y., et al. (2024) · BMJ Global Health · doi:10.1136/bmjgh-2023-014294 · Cited by 3
Scarlatta, V. R., & Defagó, M. D. (2020) · Revista de Salud Pública · doi:10.31052/1853.1180.v24.n2.28515 · Cited by 3
Consumer and Dietary Behaviour of Polish Silver Singles
Zalega, T. (2020) · Problemy Zarządzania - Management Issues · doi:10.7172/1644-9584.87.6 · Cited by 4
Questioning current recommendations on fatty acids and their role in heart health
Papadopoulou, E., & Stanner, S. A. (2014) · Nutrition Bulletin · doi:10.1111/nbu.12100 · Cited by 3
Vrints, C. J., Wood, D., Zamorano, J. L., Zannad, F. M., Karadeniz, Ş., Mezzani, A., Prescott, E., Ebrahim, S. B. J., Germanò, G., Hobbs, R. F., et al. (2013) · Cited by 3
Dietary Fatty Acids and Cardiovascular Disease: A review
Prates, R. E., von Frankenberg, A. D., & Rodrigues, T. D. C. (2015) · Clinical & Biomedical Research · doi:10.4322/2357-9730.56681 · Cited by 4
Trans fat can be a hidden health risk
Molin, M., Odden, N., Ha, L., Henriksen, T. N., Frazier, K. S., Skarpaas, A., Strand, M. F., & Westerberg, A. C. (2013) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.12.1395 · Cited by 4
“A systematic review from 2009 shows that even replacing trans fat with saturated animal fat reduces the risk of cardiovascular diseases (5).”
BackgroundRistanti, E. Y., Loppies, J. E., Ramlah, S., Wahyuni, & Ariyanti, M. (2018) · AIP conference proceedings · doi:10.1063/1.5082417 · Cited by 3
Trans Fatty Acids and Heart Health
Stender, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-08-100596-5.22509-2 · Cited by 3
The Role of Diet in the Prevention and Treatment of Cardiovascular Disease
Skulas‐Ray, A. C., Flock, M. R., & Kris‐Etherton, P. M. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-391884-0.00029-9 · Cited by 5
Effects of Dietary Lipid Intake on Diabetes
Kadegowda, A. K. G., & Yu, L. (2015) · Elsevier eBooks · doi:10.1016/b978-1-78242-247-1.00006-5 · Cited by 8
Metadata
- Authors
- Mozaffarian, D., & Clarke, R.
- Affiliations
- Brigham and Women's Hospital (US)
- University of Oxford (GB)
- Corresponding author
- Mozaffarian, D
- Venue
- European Journal of Clinical Nutrition
- Published
- 2009-05
- Volume
- 63
- Issue
- S2
- Pages
- S22-S33
- ISSN
- 0954-3007 (ISSN-L)
- 1476-5640
- OpenAlex
- W2053223480
- Cited by
- 410
- References
- 44
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 19 · 2023: 16 · 2022: 13 · 2021: 27 · 2020: 30 · 2019: 19 · 2018: 16 · 2017: 18 · 2016: 27 · 2015: 33 · 2014: 35 · 2013: 35 · 2012: 42
- FWCI
- 34.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- European Journal of Clinical Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fonterra Co-Operative Group
- National Institutes of Health (1k08hl075628-01)
- National Heart, Lung, and Blood Institute (K08-HL-075628)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- trans fatty acids, partially hydrogenated vegetable oils, coronary heart disease risk, fat replacement, saturated fatty acids, monounsaturated fatty acids, polyunsaturated fatty acids, serum lipids, lipoproteins, apolipoprotein B/apolipoprotein A-I ratio, lipoprotein(a), C-reactive protein, butter, lard, palm oil, vegetable oils, canola
- MeSH terms
- Animals, C-Reactive Protein, Cardiovascular Diseases, Cholesterol, Coronary Disease, Dietary Fats, Fatty Acids, Humans, Hydrogenation, Lipids, Plant Oils, Risk Factors, Trans Fatty Acids, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.